Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOI, etc.
Pancreatic cancer (PC) is one of the most lethal malignancies, and current treatments rarely result in long-term survival. One of the key factors defining its resilience against chemotherapy is the existence of cancer stem cells. c-Myc is a highly amplified oncogene and one of the “most wanted” targets for cancer therapy and maintains tumor stemness, which has so far been an undruggable target. Herein, we describe that a natural cyclopeptide RA-V from Rubia yunnanensis induced ER stress, reduced c-Myc expression and tumor stemness in vitro and vivo. Mechanistically, RA-V induced ER stress-mediated apoptosis through activated the PERK/eIF2α/ATF4/CHOP pathway; RA-V targeted and stabilized the ubiquitin ligase HMG-CoA reductase degradation protein 1 (HRD1), thereby mediating ER-associated degradation (ERAD) of c-Myc protein and decreasing stemness of PC cells. This study provides not only a novel pharmacological strategy to modulate the expression of c-Myc protein, but also new insights into the antitumor mechanism of RA-V.
Comments on this article